FDA D.I.S.C.O. Burst Edition: Lorbrena (lorlatinib) for patients with metastatic non-small cell l... U.S. Food and Drug Administration 4:01 5 months ago 112 Далее Скачать
FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) as adjuvant treatment for ... U.S. Food and Drug Administration 3:31 5 months ago 45 Далее Скачать
FDA D.I.S.C.O. Burst Edition: FDA approval of Imjudo (tremelimumab) in combination with Imfinzi (... U.S. Food and Drug Administration 3:01 5 months ago 61 Далее Скачать
FDA D.I.S.C.O. Burst Edition: FDA approval of Augtyro (repotrectinib) for locally advanced or met... U.S. Food and Drug Administration 3:00 5 months ago 126 Далее Скачать
FDA D.I.S.C.O. Burst Edition: FDA approval of Lytgobi (futibatinib) for adult patients with previ... U.S. Food and Drug Administration 3:01 5 months ago 45 Далее Скачать
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer U.S. Food and Drug Administration 6:01 5 months ago 35 Далее Скачать
FDA D.I.S.C.O. Burst Edition: FDA approval of Xalkori (crizotinib) for ALK-positive inflammatory ... U.S. Food and Drug Administration 3:01 5 months ago 25 Далее Скачать
FDA D.I.S.C.O.: Two approvals for ALK-positive non-small cell lung cancer U.S. Food and Drug Administration 9:00 5 months ago 186 Далее Скачать
FDA approved Rybrevant and Lazcluze for patients with non-small cell lung cancer | Chemo-free trt Pharmacist and Drugs 1:00 11 days ago 34 Далее Скачать
Dr. West on FDA Approval of Frontline Alectinib in ALK+ NSCLC OncLive 0:55 7 years ago 123 Далее Скачать
Dr. Horn on the FDA Approval of Atezolizumab Plus Bevacizumab and Chemotherapy in NSCLC OncLive 1:08 5 years ago 681 Далее Скачать
FDA Approval of Durvalumab for Stage III Unresectable NSCLC OncLive 1:36 6 years ago 545 Далее Скачать
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer ReachMD 9:00 5 months ago 2 Далее Скачать
Dr. West on FDA Approval of Afatinib in NSCLC With Rare EGFR Mutations OncLive 1:47 6 years ago 398 Далее Скачать
Dr. Lopes on the FDA Approval of Nivolumab/Ipilimumab in NSCLC OncLive 0:39 4 years ago 318 Далее Скачать
FDA Approval in NSCLC, Priority Review in SCLC, 2018 SABCS Highlights, and More OncLive 7:23 5 years ago 84 Далее Скачать
FDA Approval and Priority Review in Ovarian Cancer, End of Part B Payment Model, and More OncLive 6:24 7 years ago 54 Далее Скачать